News

You can reach reporter Mike Francis at mike@thelundreport.org. FILE - Dr. Vinay Prasad at Oregon Health & Science University, Nov. 22, 2016. Prasad was named director of the U.S. Food and Drug ...
The U.S. FDA has appointed Vinay Prasad to be the next director of its Center for Biologics Evaluation and Research division (CBER), the agency's Commissioner Martin Makary posted on the social ...
The Food and Drug Administration (FDA) has tapped Vinay Prasad, a prominent critic of federal COVID-19 policies and a proponent of more stringent approval standards, to lead the agency’s ...
The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist, to lead its Center for Biologics Evaluation and Research, the division that oversees vaccines and ...
The US Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized COVID-19 restrictions, as the director of its Center for Biologics Evaluation and Research ...
Find him on Twitter @GabeWhisnant. Dr. Vinay Prasad, a known critic of both the pharmaceutical industry and the Food and Drug Administration, has been appointed to lead the FDA's program ...
The Food and Drug Administration announced Tuesday it has picked a new head of its center charged with vaccine approvals and other biologics products: Dr. Vinay Prasad, a vocal critic of the ...
FDA Commissioner Marty Makary named Vinay Prasad, a hematologist oncologist and critic of the Covid-19 vaccine for children, as the next director of the Center for Biologics and Research.
FDA Commissioner Marty Makary, M.D., has named Vinay Prasad, M.D., to the post, he said in a post on X. "Dr. Prasad brings the kind of scientific rigor, independence, and transparency we need at ...
It’s difficult to know exactly what’s going on in their heads. Not Vinay Prasad. The new top regulator of vaccines and gene therapies at the Food and Drug Administration has never shied away ...
05. Matthew Herper covers medical innovation — both its promise and its perils. WASHINGTON — Vinay Prasad, an academic and fierce critic of the medical mainstream, will be the next director ...